Glucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide — better known as Ozempic — have gained popularity globally, not just for managing type 2 diabetes but also due to their weight loss benefits. This increase in…
Glucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide — better known as Ozempic — have gained popularity globally, not just for managing type 2 diabetes but also due to their weight loss benefits. This increase in…
Welcome to a place where big ideas and creative stories come to life.
We share real thoughts, fresh trends, and powerful voices that inspire and inform.
This is more than just a magazine — it’s a new way to see the world.
©2025 CBS Magazine. All Rights Reserved By Pytechgenius Consulting
